ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration

Figure 1

ATAD2 is highly expressed in endometrial cancer and correlates with the OS of the patient. (a) TIMER database assessment of ATAD2 expression in pan-cancer. (b) UALCAN-based analysis of ATAD2 mRNA expression in UCEC. (c) Impact of ATAD2 expression in UCEC on patient OS. (d) HPA analysis of ATAD2 protein expression in UCEC. (e, f) UALCAN assessment of ATAD2 and uterine endometrial cancer patients with clinical information correlation. (g) Expression of ATAD2 in human endometrial epithelial cells and four endometrial cancer cell lines. (h) Expression of ATAD2 in endothelial cancer cell lines after overexpression and knockdown of ATAD2.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)